NNVC plans Phase II trial of NV-387 oral gummies in DR Congo
NNVC says a Phase II clinical trial of NV-387 oral gummies as a treatment for Ebola in DR Congo is set to begin soon.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.